BYG4lab® signs a partnership agreement with GeodAIsics to strengthen Ynfectio®, the epidemiology and infection control software, with an A.I. module.

BYG4lab®, leader in data management solutions for medical biology, announces its partnership with GeodAIsics, a company that develops clinical decision support software based on generative Artificial Intelligence.

In healthcare facilities, the early detection of healthcare associated infections and the ability to alert on possible contaminations with multidrug resistant organisms are a major public health issue. The impact is both medical and economic.

Combining the use of Ynfectio® with the generative Artificial Intelligence solution developed by GeodAIsics will provide a more accurate warning on the appearance of clusters, so preventive and corrective measures can be taken as early as possible. GeodAIsics will use all the data generated from Ynfectio® combined with its A.I. expertise to detect cross-contaminations.

Today’s announcement highlights the ongoing commitment of BYG4lab® and
GeodAIsics to provide innovative solutions in human healthcare.

Arnaud Attyé, C.E.O GeodAIsics : « This partnership with BYG4lab® is an important step in diversifying the applications provided by our A.I. algorithms. It opens unique opportunities to analyse subtle trends and provide crucial information for healthcare facilities. »

Cyril Verhille, C.E.O BYG4lab® : « The GeodAIsics A.I. algorithms combined with our expertise in the epidemiology and infection control fields will enable us to maximise the use of the data available in our Ynfectio® solutions and more generally in the institutions. We are delighted to be able to make an even more active contribution to improving patient care within healthcare facilities. »

 

To read the full press release, please click here